More recently, we found that a selective change in gut microbiota composition through inulin-type prebiotic treatment improves gut barrier functions through a GLP-2-dependent mechanism during obesity and diabetes [4]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.